pipette
ESEspañol

A tri-modular feline infectious peritonitis virus nanoparticle vaccine confers complete protection in female cats without detectable antibody-dependent enhancement

Feiyu Zhao, Dan Yang, Haixin Liu, Qinghe Zhu, Fanbo Shen, Jiongze Cheng, Xinglin Wang, Wei Zhou, Weiyue Jiang, Xiaoxi Yu, Tianshu Liu, Zhen Li, Wenqiang Xu, Lan Bi, Shanshan Qi, Da Shi, Jialin Zhang, Li Feng, Yung‐Fu Chang, Mingjun Su, Sun Dongbo

Peer-reviewed journal

In the authors' words

Antibody-dependent enhancement (ADE) complicates coronavirus vaccine development. Feline infectious peritonitis virus (FIPV) is a classic model of coronavirus vaccine-mediated ADE. Here, we develop ferritin-based FIPV nanoparticle vaccines displaying nucleocapsid (N) antigen, antigen-presenting cell (APC)-targeting ligands, and immunostimulatory factors, and evaluate their protective efficacy, serum-mediated ADE risk, and associated immune features. Compared with soluble N protein, the single-module FIPV N nanoparticle vaccine (sfNnps) enhances FIPV N-specific T-cell responses yet confers only 25.0% (2/8) protection. Dual-module vaccines incorporating either the APC-targeting ligand HCV E2 (dfN/Hnps) or the immunostimulatory factor IFNγ (dfN/Inps) further boost N-specific T-cell responses and confer 50.0% (4/8) and 62.5% (5/8) protection, respectively. The tri-modular vaccine co-displaying N, HCV E2, and IFNγ (tfN/HInps) elicits the most robust N-specific T-cell responses and affords 100% (8/8) protection in female cats, while showing no detectable serum-mediated ADE under the tested conditions and reducing peripheral-blood viral RNA levels by 73.0%. Immune profiling associates tfN/HInps with increased cDC1 representation and antigen-presentation gene expression, as well as a shift toward CD8⁺ effector-memory T cells and a FOXO1-centered program linked to transcriptional features of increased proliferation, memory formation, and cytotoxicity. Overall, this engineered FIPV nano‑display vaccine could provide a framework for cellular‑immunity‑oriented vaccine development against ADE‑prone coronaviruses. This study shows that a tri-modular ferritin nanoparticle vaccine against feline infectious peritonitis virus elicits strong cellular immunity and provides protection in female cats without detectable serum-mediated antibody-dependent enhancement.

Main resultLimitation the authors admit

Appeared: Wednesday, October 28. Nature Communications. Peer-reviewed journal.

DOI: 10.1038/s41467-026-78999-4